Erratum: Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: A cross-sectional analysis (Medicine (United States) 95:20 (e3572) DOI: 10.1097/MD.0000000000003572);Medication Adherence and Blood Pressure Control Among Hypertensive Patients With Coexisting Long-Term Conditions in Primary Care Settings

Medicine (United States)

Volumn 95, Issue 20, 2016, Pages

  Li, Yu Ting ^a,b   Wang, Harry H X ^a   Liu, Kirin Q L ^b   Lee, Gabrielle K Y ^b   Chan, Wai Man ^b   Griffiths, Sian M ^b   Chen, Ruo Ling ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NEPHRITIS; PATIENT COMPLIANCE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; BLOOD PRESSURE; HEART DISEASES; HONG KONG; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEART DISEASES; HONG KONG; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84973542623     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000007831     Document Type: Erratum

References (55)

1. Bromfield S, Muntner P. High blood pressure: The leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013; 15:134-136.
2. Lawes CMM, Vander Hoorn S, Rodgers A, et al. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371:1513-1518.
3. Ohta Y, Tsuchihashi T, Onaka U, et al. Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients. Intern Med. 2010; 49:1483-1487.
4. Wong MCS, Wang HHX, Cheung CSK, et al. Factors associated with multimorbidity and its link with poor blood pressure control among 223, 286 hypertensive patients. Int J Cardiol. 2014; 177:202-208.
5. Ogden LG, He JA, Lydick E, et al. Long-Term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000; 35:539-543.
6. Fortin M, Bravo G, Hudon C, et al. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005; 3:223-228.
7. Gallacher KI, Batty G, McLean G, et al. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1, 424, 378 patients in Scotland: implications for treatment burden BMC Med. 2014; 12:151.
8. Wang HHX, Wang JJ, Wong SYS, et al. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162, 464 community household residents in southern China. BMC Med. 2014; 12:188.
9. Wang HHX, Wang JJ, Lawson KD, et al. Relationships of multimorbidity and income with hospital admissions in 3 health care systems. Ann Fam Med. 2015; 13:164-167.
10. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet. 2012; 380:37-43.
11. Stange KC. In this issue: challenges of managing multimorbidity. Ann Fam Med. 2012; 10:2-3.
12. Bayliss EA, Ellis JL, Steiner JF. Barriers to self-management and quality-of-life outcomes in seniors with multimorbidities. Ann Fam Med. 2007; 5:395-402.
13. Lo YY, Lam CL, Mercer SW, et al. Patient morbidity and management patterns of community-based primary health care services in Hong Kong. Hong Kong Med J. 2011; 17:33-37.
14. Wong MCS, Wang HHX, Leung MCM, et al. The rising prevalence of self-reported hypertension among Chinese subjects: A populationbased study from 121, 895 household interviews. QJM-An Int J Med. 2015; 108:9-17.
15. Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings. Task Force on Conceptual Model and Preventive Protocols of the Working Group on Primary Care. The Government of Hong Kong Special Administrative Region. 2010.
16. Neal B, MacMahon S, Chapman N, et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000; 356:1955-1964.
17. Whelton PK. The elusiveness of population-wide high blood pressure control. Annu Rev Public Health. 2015; 36:109-130.
18. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension, prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003; 289:2363-2369.
19. Pereira M, Lunet N, Azevedo A, et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009; 27:963-975.
20. Guo F, He D, Zhang W, et al. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012; 60:599-606.
21. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34:2159-2219.
22. Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014; 37:253-387.
23. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003; 289:2560-2572.
24. Wang JG. Chinese hypertension guidelines. Pulse (Basel). 2015; 3:14-20.
25. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008; 10:348-354.
26. Lee GKY, Wang HHX, Liu KQL, et al. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. Plos One. 2013; 8:e62775.
27. Wong MCS, Liu KQL, Wang HHX, et al. Effectiveness of a pharmacist-led drug counseling on enhancing antihypertensive adherence and blood pressure control: A randomized controlled trial. J Clin Pharmacol. 2013; 53:753-761.
28. Wong MCS, Wu CHM, Wang HHX, et al. Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) score and glycaemic control among Chinese diabetes patients. J Clin Pharmacol. 2015; 55:279-287.
29. Huntley AL, Johnson R, Purdy S, et al. Measures of multimorbidity and morbidity burden for use in primary care and community settings: A systematic review and guide. Ann Fam Med. 2012; 10:134-141.
30. Fortin M, Stewart M, Poitras ME, et al. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Ann Fam Med. 2012; 10:142-151.
31. Thematic Household Survey (2011), Census and Statistics Department, The Government of Hong Kong Special Administrative Region. 2011.
32. Paulsen MS, Andersen M, Thomsen JL, et al. Multimorbidity and blood pressure control in 37, 651 hypertensive patients from Danish general practice. J Am Heart Assoc. 2013; 2:e004531.
33. Kish L. Survey Sampling. New York: Chichester: Wiley; 1965:(1995 [printing]).
34. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996; 49:1373-1379.
35. Wang HHX, Wong MCS, Mok RY, et al. Factors associated with grade 1 hypertension: implications for hypertension care based on the Dietary Approaches to Stop Hypertension (DASH) in primary care settings. BMC Fam Pract. 2015; 16:26.
36. Wong MCS, Wang HHX, Kwan MWM, et al. Dietary counselling has no effect on cardiovascular risk factors among Chinese Grade 1 hypertensive patients: A randomized controlled trial. Eur Heart J. 2015; 36:2598-2607.
37. Kang CD, Tsang PP, Li WT, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: A cross-sectional study. Int J Cardiol. 2015; 182:250-257.
38. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev. 2011; 10:430-439.
39. Mercer SW, Watt GC. The inverse care law: clinical primary care encounters in deprived and affluent areas of Scotland. Ann Fam Med. 2007; 5:503-510.
40. Meredith PA, Lloyd SM, Ford I, et al. Importance of sustained and tight blood pressure control in patients with high cardiovascular risk. Blood Press. 2016; 25:74-82.
41. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004; 18:139-185.
42. Lipman ML, Schiffrin EL. What is the ideal blood pressure goal for patients with diabetes mellitus and nephropathy? Curr Cardiol Rep. 2012; 14:651-659.
43. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens (Greenwich). 2008; 10:644-646.
44. Sarkar C, Dodhia H, Crompton J, et al. Hypertension: A crosssectional study of the role of multimorbidity in blood pressure control. BMC Fam Pract. 2015; 16:98.
45. Krousel-Wood M, Thomas S, Muntner P, et al. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004; 19:357-362.
46. Daugherty SL, Powers JD, Magid DJ, et al. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Hypertension. 2012; 60:303-309.
47. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: A meta-Analysis. Med Care. 2007; 45:521-528.
48. Margolis KL, Asche SE, Bergdall AR, et al. A successful multifaceted trial to improve hypertension control in primary care: Why did it work? J Gen Intern Med. 2015; 30:1665-1672.
49. Bertoia ML, Waring ME, Gupta PS, et al. Implications of new hypertension guidelines in the United States. Hypertension. 2011; 58:361-366.
50. Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf. 2004; 13:83-87.
51. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004; 351:2870-2874.
52. Sharman JE, Blizzard L, Kosmala W, et al. Pragmatic method using blood pressure diaries to assess blood pressure control. Ann Fam Med. 2016; 14:63-69.
53. Wallace E, Salisbury C, Guthrie B, et al. Managing patients with multimorbidity in primary care. BMJ. 2015; 350:h176.
54. Mercer SW, Gunn J, Bower P, et al. Managing patients with mental and physical multimorbidity. BMJ. 2012; 345:e5559.
55. Moffat K, Mercer SW. Challenges of managing people with multimorbidity in todays healthcare systems. BMC Fam Pract. 2015; 16:129.